3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Breast Neoplasms
6
Neuroendocrine Tumors
5
Neoplasm Metastasis
3
Carcinoma, Renal Cell
3
Tuberous Sclerosis
2
Triple Negative Breast Neoplasms
2
Recurrence
2
Glioma
2
Endometrial Neoplasms
2
Adenoma, Islet Cell
2
von Hippel-Lindau Disease
1
Vascular Malformations
1
Unilateral Breast Neoplasms
1
Thymus Neoplasms
1
Seizures
1
Sarcoma, Kaposi
1
Sarcoma
1
Nevus
1
Myelodysplastic Syndromes
1
Multiple Endocrine Neoplasia Type 1
1
Metastatic Digestive System Neuroendocrine Tumor G1
1
Meningioma
1
Lymphangioma
1
Liposarcoma
1
Leukemia, Myeloid, Acute
1
Leiomyosarcoma
1
Kidney Neoplasms
1
Hemangioma
1
Hemangioendothelioma
1
Hamartoma Syndrome, Multiple
1
Interventions
Cyclophosphamide
3
fludarabine phosphate
2
Whole-Body Irradiation
2
Tacrolimus
2
Specimen Handling
2
Peripheral Blood Stem Cell Transplantation
2
Nivolumab
2
Mycophenolic Acid
2
Busulfan
2
Biopsy
2
talimogene laherparepvec
1
pembrolizumab
1
fludarabine
1
duvelisib
1
Vincristine
1
Transplantation
1
Sirolimus
1
Radiotherapy
1
Prednisone
1
Methotrexate
1
Melphalan
1
Magnetic Resonance Spectroscopy
1
Gemcitabine
1
Etoposide
1
Cyclosporine
1
Brentuximab Vedotin
1
Blood Specimen Collection
1
Aclarubicin
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Sezary Syndrome
×
Everolimus
×
90 days
×
Clear all
No trials found.